Bio-Rad Laboratories BIO
NYSE BIO
$363.63 +3.13 (+0.87%)
As of: Oct 22, 2026 · 3:59 PM EDT

Bio-Rad Laboratories (BIO) Accumulated Expenses (2013 - 2014)

Updated

Analysis

Bio-Rad Laboratories (BIO) Accumulated Expenses (2013 - 2014) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 250.71 Bn 229.74 Bn 4.88 Bn
2 Abbott Laboratories 178.38 Bn 148.81 Bn 7.27 Bn
3 Danaher 161.61 Bn 145.42 Bn 3.61 Bn
4 Intuitive Surgical 154.15 Bn 134.44 Bn 2.08 Bn
5 Medtronic 123.21 Bn 88.46 Bn 6.34 Bn
6 Stryker 117.50 Bn 103.61 Bn 4.50 Bn
7 Boston Scientific 67.50 Bn 62.26 Bn 3.85 Bn
8 Becton Dickinson 54.80 Bn 51.95 Bn 2.32 Bn
9 Edwards Lifesciences 51.78 Bn 35.79 Bn 1.35 Bn
10 Bio-Rad Laboratories 9.70 Bn 3.56 Bn 345.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2014 4.22 Mn
Dec 31, 2013 6.07 Mn
API Access

Bio-Rad Laboratories Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=BIO&period=max&api_key=YOUR_API_KEY